Terms: = Breast cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
12 results:
1. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
2. An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (msh6) in human tumors.
Zhan H; Mo F; Xu Q; Wang S; Zhang B; Liu X; Dai M; Liu H
Aging (Albany NY); 2021 Dec; 13(23):25271-25290. PubMed ID: 34941572
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathologic Characteristics of Endometrial cancer in Lynch Syndrome: A French Multicenter Study.
Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
Leo F; Bartels S; Mägel L; Framke T; Büsche G; Jonigk D; Christgen M; Lehmann U; Kreipe H
Virchows Arch; 2016 Aug; 469(2):191-201. PubMed ID: 27220763
[TBL] [Abstract] [Full Text] [Related]
5. The genetic prediction of risk for gynecologic cancers.
Randall LM; Pothuri B
Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
[TBL] [Abstract] [Full Text] [Related]
6. Microsatellite Instability as a Biomarker for PD-1 Blockade.
Dudley JC; Lin MT; Le DT; Eshleman JR
Clin Cancer Res; 2016 Feb; 22(4):813-20. PubMed ID: 26880610
[TBL] [Abstract] [Full Text] [Related]
7. Obesity and the outcome of young breast cancer patients in the UK: the POSH study.
Copson ER; Cutress RI; Maishman T; Eccles BK; Gerty S; Stanton L; Altman DG; Durcan L; Wong C; Simmonds PD; Jones L; Eccles DM;
Ann Oncol; 2015 Jan; 26(1):101-112. PubMed ID: 25361993
[TBL] [Abstract] [Full Text] [Related]
8. Combined genetic and nutritional risk models of triple negative breast cancer.
Lee E; Levine EA; Franco VI; Allen GO; Gong F; Zhang Y; Hu JJ
Nutr Cancer; 2014; 66(6):955-63. PubMed ID: 25023197
[TBL] [Abstract] [Full Text] [Related]
9. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
Santarpia L; Iwamoto T; Di Leo A; Hayashi N; Bottai G; Stampfer M; André F; Turner NC; Symmans WF; Hortobágyi GN; Pusztai L; Bianchini G
Oncologist; 2013; 18(10):1063-73. PubMed ID: 24072219
[TBL] [Abstract] [Full Text] [Related]
10. Hereditary genes and SNPs associated with breast cancer.
Mahdi KM; Nassiri MR; Nasiri K
Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
[TBL] [Abstract] [Full Text] [Related]
11. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
Copson E; Eccles B; Maishman T; Gerty S; Stanton L; Cutress RI; Altman DG; Durcan L; Simmonds P; Lawrence G; Jones L; Bliss J; Eccles D;
J Natl Cancer Inst; 2013 Jul; 105(13):978-88. PubMed ID: 23723422
[TBL] [Abstract] [Full Text] [Related]
12. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract] [Full Text] [Related]